GLP-1 Therapy for PMOS and Insulin Resistance

Insulin resistance is the most common driver behind PMOS, previously known as PCOS. That is why GLP-1 for PCOS gets asked about so often. A therapy aimed at weight and insulin can change menstrual cycles and androgen markers, even though it is not a treatment for PMOS.

Why insulin matters in PMOS

High insulin pushes the ovaries to produce more androgen, and at the same time lowers the carrier protein that binds those hormones in the blood. Free androgen rises twice over: more is produced, and less is bound. The symptoms that follow, such as irregular cycles, acne, facial hair and weight that will not move, largely come from there.

Where GLP-1 for PCOS fits

GLP-1 therapy is not a registered treatment for PMOS. It is used when obesity or type 2 diabetes are present alongside it, and its effect on PMOS is indirect. When weight and insulin resistance come down, fasting insulin falls, free androgen drops, and in some women cycles become more regular. That is a downstream effect, not the medicine’s target.

What is tried first

Changes to eating, resistance training and sleep remain the base, because all three act directly on insulin sensitivity. Metformin is still a common early option for insulin resistance. If the main problem is cycles and androgen symptoms rather than weight, the treatment route is entirely different. That is why the driver has to be identified first.

Not every case of PMOS is insulin-driven

Some patients with PMOS have a normal weight and normal fasting insulin. For them, a weight-lowering medicine solves nothing. Other patterns include inflammation-driven, adrenal-axis driven, and the pattern that appears after stopping hormonal contraception. Read PMOS symptoms and why the driver matters for an explanation of these patterns.

The thing that gets missed most often

When insulin resistance improves, fertility can return faster than expected. GLP-1 therapy is not used in pregnancy, so reliable contraception needs discussing before starting, not after. This is one of the main reasons the pre-prescription assessment is done carefully in PMOS patients.

What gets checked and monitored

• Fasting glucose, HbA1c and insulin resistance markers
• Androgens, including the carrier protein that binds them
• Thyroid function, since it mimics the same symptoms
• Lipid profile and fatty liver markers
• Body composition, not weight alone
• A cycle record kept through the programme

See the metabolic assessment and hormone profile for what is included. Read who is eligible for GLP-1 therapy and GLP-1 therapy and muscle loss as well. Book a consultation for an assessment.

For the full picture of the doctor-led programme and where GLP-1 therapy fits, see doctor-led GLP-1 and weight management.

The WHO fact sheet gives a short overview of the condition.

Every iLIV guide is written and reviewed under our editorial standards, and each one carries the name of the reviewing doctor together with their MMC registration number.

Frequently Asked